Turkey Overhauls Overseas Drug Procurement with New System
Translated from Turkish, summarized and contextualized by DistantNews.
TLDR
- Turkey's Social Security Institution (SGK) is implementing a new system for purchasing medication from abroad.
- The new
Turkey's Social Security Institution (SGK) is overhauling its system for procuring medicines from overseas, aiming for greater efficiency and cost savings. This strategic shift, detailed in the 'İŞ'İN DOĞRUSU' publication, introduces a "dynamic procurement system" and a "Foreign Procurement Commission" to negotiate prices and ensure a transparent, competitive process.
Hastaların tedaviye kesintisiz erişimini güvence altına almayı önceleyen, kamu kaynaklarının etkin kullanımını hedefleyen yeni sistemde, ilaç alımları şeffaf ve rekabet arttırılarak gerçekleştirilecek.
The SGK, which already sources nearly 100 cancer drugs internationally, spent 411.6 billion Turkish Liras on pharmaceuticals in 2025 and anticipates this figure to climb to 600 billion Liras by 2026. The new measures are projected to not only secure uninterrupted patient access to vital treatments but also to optimize public funds. In 2025 alone, the institution reported savings of 470,000 euros through the registration of cheaper equivalent drugs and price reductions.
Artık ilaç alımı "Yurt Dışı Alım Komisyonu" tarafından, pazarlık yapılarak "dinamik alım sistemi" ile yapılacak.
The "dynamic procurement system" allows for open applications from eligible suppliers, with evaluations based on pre-defined criteria, though price offers are deferred to a later stage. This approach aims to foster competition and secure the best possible terms. The establishment of a dedicated "Foreign Procurement Commission" will further streamline decision-making, considering factors like estimated needs, budget constraints, and urgency before presenting procurement plans for approval.
SGK, alımlarda saydamlığı, rekabeti, eşit muameleyi, güvenilirliği, gizliliği, ihtiyaçların uygun şartlarla ve zamanında karşılanmasını ve kaynakların verimli kullanılmasını sağlayacak
This reform underscores Turkey's commitment to modernizing its healthcare procurement, ensuring both the availability of essential medicines and the prudent use of taxpayer money. The emphasis on negotiation and a competitive bidding process reflects a broader national strategy to enhance economic efficiency across public services, a narrative often highlighted in Turkish media as a sign of responsible governance and forward-thinking policy.
Yurt dışında ilaç alımı için Yurt Dışı İlaç Alım Komisyonu kurulacak.
Originally published by Sabah in Turkish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.